Pi Therapeutics Ltd.

www.pi-tx.com

High-Tech Company

Ceased to Operate Q3/2021

Graduated from: FutuRx

TECH VERTICALS

Biotechnology, Cancer, Life Sciences, MedTech, Protein, Therapeutics

General Data

Sector	Biomed
Company Stage:	R&D
Established	2015
Number of Employees	7
Reg. Number:	abCDe

DESCRIPTION

Pi Therapeutics is a preclinical-stage pharmaceutical company dedicated to the development of protein degradation modulators for the treatment of cancer. PI's lead drug modulates pathways related to proteostasis, offering a unique approach to the preferential targeting of cancer cells. Preclinical data to date have demonstrated a compelling safety and efficacy profile which is differentiated from approved protein degradation inhibitors.

TECHNOLOGY

Pi developed a novel inhibitor of protein degradation that generated encouraging pre-clinical activity in multiple models of liquid and solid tumors.

Products and Phases

Product	Phase
N/A	Phase I
A novel inhibitor of protein degradation that generated encouraging pre-clinical activity in multiple models of liquid and solid tumors.

	TARGET MARKETS
	Cancer Patients, Oncologists.

	BUSINESS MODEL
	B2C

REMARKS

Date	Remark
	The company was established based on technology in-licensed from Johns Hopkins University.

CONTACT INFO

Expand / Collapse All

Main Address: Ness Ziona, Israel

Address	2 Ilan Ramon St., 3rd Floor, Kiryat Weizmann Science Park
POB	4044
City	Ness Ziona
Country	Israel
Zip	7403635

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Ori Kalid	Founder

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round

May. 29, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Bank	abCDe

First Round

Jun. 01, 2017

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe

Seed

Mar. 01, 2015

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe